Abstract

Interspinous process devices (IPDs) are implanted to treat patients with intermittent neurogenic claudication (INC) based on lumbar spinal stenosis. It is hypothesized that patients with lumbar spinal stenosis treated with IPD have a faster short-term recovery, an equal outcome after 2years and less back pain compared with bony decompression. A randomized design with variable block sizes was used, with allocations stratified according to center. Allocations were stored in prepared opaque, coded and sealed envelopes, and patients and research nurses were blind throughout the follow-up. Five neurosurgical centers (including one academic and four secondary level care centers) included participants. 211 participants were referred to the Leiden-The Hague Spine Prognostic Study Group. 159 participants with INC based on lumbar spinal stenosis at one or two levels with an indication for surgery were randomized into two groups. Patients and research nurses were blinded for the allocated treatment throughout the study period. 80 participants received an IPD and 79 participants underwent spinal bony decompression. The primary outcome at long-term (2-year) follow-up was the score for the Zurich Claudication Questionnaire. Repeated measurement analyses were applied to compare outcomes over time. At two years, the success rate according to the Zurich Claudication Questionnaire for the IPD group [69% (95% CI 57-78%)] did not show a significant difference compared with standard bony decompression [60% (95% CI 48-71%) p value 0.2]. Reoperations, because of absence of recovery, were indicated and performed in 23 cases (33%) of the IPD group versus 6 (8%) patients of the bony decompression group (p<0.01). Furthermore, long-term VAS back pain was significantly higher [36mm on a 100mm scale (95% CI 24-48)] in the IPD group compared to the bony decompression group [28mm (95% CI 23-34) p value 0.04]. This double-blinded study could not confirm the advantage of IPD without bony decompression over conventional 'simple' decompression, two years after surgery. Moreover, in the IPD treatment arm, the reoperation rate was higher and back pain was even slightly more intense compared to the decompression treatment arm.

Highlights

  • Intermittent neurogenic claudication (INC) caused by lumbar spinal stenosis (LSS) is common in the elderly [1± 3]

  • At two years, the success rate according to the Zurich Claudication Questionnaire for the Interspinous process devices (IPDs) group

  • In the IPD treatment arm, the reoperation rate was higher and back pain was even slightly more intense compared to the decompression treatment arm

Read more

Summary

Introduction

Intermittent neurogenic claudication (INC) caused by lumbar spinal stenosis (LSS) is common in the elderly [1± 3]. Some centers even opt for combining bony decompression with instrumented spondylodesis (pedicle screws and/or intercorporal cages) as the golden standard for treatment of patients with INC caused by LSS [14±16]. In (elderly) patients with LSS due to arthrosis of the facet joints, implantation of interspinous process device (IPD) is regularly offered instead of conventional bony decompression [17, 18]. Neurogenic claudication treatment with IPD has been demonstrated to be superior compared with conservative care [19±23]. The IPD was developed to increase the interspinous distance with indirect decompression of the dural sac and nerve roots due toexion of the involved segments, and to widen the entry of the spinal root canal at the same time [17±19, 24±30]. Patients are hypothetically expected to have less postoperative pain, a shorter hospital stay, a faster short-term recovery and less back pain at long-term follow-up

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call